Live Breaking News & Updates on George Grofik

Stay updated with breaking news from George grofik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript

Royalty Pharma plc (NASDAQ:RPRX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Terry-coyne , Chris-schott , Geoff-meacham , Terrance-coyne , Chris-shibutani , Marshall-urist , Pablo-legorreta , George-grofik , Repros-therapeutics-inc , Goldman-sachs

Royalty Pharma plc (NASDAQ:RPRX) Q4 2023 Earnings Call Transcript

Royalty Pharma plc (NASDAQ:RPRX) Q4 2023 Earnings Call Transcript February 15, 2024 Royalty Pharma plc beats earnings expectations. Reported EPS is $1.15, expectations were $1.01. RPRX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for […] ....

United-states , America , Geoff-meacham , George-grofik , Pablo-legorreta , Quality-fried-chicken-chains-in-the , Best-birth-injury-lawyers , Royalty-pharma , Pablo-legorreta , Transactions , Receipts

Royalty Pharma plc (NASDAQ:RPRX) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma Third Quarter 2023 Earnings Conference Call. ....

Chris-schott , Stephen-scala , George-grofik , Christopher-schott , Andrew-baum , Marshall-urist , Pablo-legorreta , Terrance-coyne , Terry-coyne , Repros-therapeutics-inc , Nasdaq , Life-sciences

Royalty Pharma plc (NASDAQ:RPRX) Q1 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma First Quarter Earnings Conference Call. ....

Chris-shibutani , Chris-schott , Astrazeneca-airsupra , Pablo-legorreta , Karuna-kar , Marshall-urist , George-grofik , Terry-coyne , Health-photo , Repros-therapeutics-inc , Life-sciences , Goldman-sachs